Gut Microbial Butyrate Metabolism Generates an N-Acyl Amide that Regulates Host Transcriptional Programs
Faecalibacterium prausnitzii is a prominent member of the human gut microbiota whose depletion is associated with various intestinal and metabolic disorders. While multiple mechanisms have been proposed to explain how F. prausnitzii promotes host health, the molecular determinants underlying these activities remain elusive. Here, we show that F. prausnitzii is a prolific producer of the human metabolite N-butyrylglycine, which we find accumulates to millimolar concentrations in bacterial culture and is readily detectable in the feces of conventional wildtype mice. We establish an enzymatic basis of N-butyrylglycine production by identifying and biochemically validating an F. prausnitzii N-acyltransferase that catalyzes the conjugation of butyryl-CoA and glycine. Despite being derived from butyrate, N-butyrylglycine exhibits distinct bioactivity from its precursor, including reduced histone deacetylase inhibitory activity, an altered inflammatory profile, and enhanced suppression of cellular proliferation across multiple cancer cell lines. Furthermore, transcriptomic profiling revealed N butyrylglycine coordinates repression of G2/M checkpoint-associated programs and downregulation of the colorectal cancer associated gene AOC1. Together, these findings suggest that specialized metabolites produced by F. prausnitzii contribute to its beneficial effects and may underlie its protective role in colorectal cancer.
Authors
- Randy Hamchand (ORCID: https://orcid.org/0000-0002-9078-7550)
- Pamela V. Chang (ORCID: https://orcid.org/0000-0003-3819-9994)
Institutions
- Cornell University (US)
Publication Details
- Journal
- bioRxiv (Cold Spring Harbor Laboratory)
- Published
- 2026-11-17
- DOI
- https://doi.org/10.64898/2026.11.16.766927
- Primary Topic
- Gut microbiota and health
- Type
- preprint
Funders
- National Science Foundation
- Alfred P. Sloan Foundation